18
Participants
Start Date
October 5, 2000
Primary Completion Date
November 29, 2005
Study Completion Date
Thalidomide
MD Anderson Cancer Center, Houston
Collaborators (1)
Celgene
INDUSTRY
M.D. Anderson Cancer Center
OTHER